Fig. 3From: TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerValidation of the risk score model. A Univariate cox proportional hazard model in the train cohort. B Multivariate cox proportional hazard model in the train cohort. C PCA analysis in the train cohort. D PCA analysis in the test cohort. F t-SNE analysis in the train cohort. G t-SNE analysis in the test cohort. E Time-dependent ROC curves of the risk score model for predicting 1-, 3- and 5-years in the train cohort. H Time-dependent ROC curves of the risk score model for predicting 1-, 3- and 5-years in the test cohortBack to article page